SEC Form 4 · accession 0001919246-26-000093
Pelthos Therapeutics Inc. · PTHS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ezra M Friedberg
Director
Period of report
Jun 15, 2026
Accepted (ET)
Jun 17, 2026 · 5:25 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001919246
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Jun 15, 2026 | S | 224 | $27.1245 | D | 81,659 | D | |
| Common StockF3 | Jun 15, 2026 | S | 59 | $27.9403 | D | 81,600 | D | |
| Common StockF4 | holding | — | — | — | 82,072 | I | By Balmoral Financial Group LLC | |
| Common StockF4 | holding | — | — | — | 40,000 | I | By Key Recovery Group LLC |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This transaction reflects the sale of shares, made pursuant to a Rule 10b5-1 plan adopted December 16, 2025, for the purpose of satisfying estimated tax obligations in connection with the vesting of restricted stock units granted by the Issuer.
- F2This transaction was executed in multiple trades at prices ranging from $26.71 to $27.44. The price reported in column 4 above reflects the weighted average price of the shares of Common Stock sold. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F3This transaction was executed in multiple trades at prices ranging from $27.92 to $28.00. The price reported in column 4 above reflects the weighted average price of the shares of Common Stock sold. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F4Ezra Friedberg is the manager of Balmoral Financial Group LLC ("Balmoral") and the manager of Key Recovery Group LLC ("Key"). By virtue of this relationship, Mr. Friedberg may be deemed to beneficially own the shares of Common Stock held of record by each of Balmoral and Key. Mr. Friedberg disclaims any such beneficial ownership except to the extent of his pecuniary interest therein.